If You Need Cefepime, You're Not Alone in the Search

If your doctor has prescribed Cefepime and you've been told it's unavailable or on backorder, you're dealing with a frustrating reality that thousands of patients and providers face in 2026. Cefepime — a powerful fourth-generation cephalosporin antibiotic — has been in and out of shortage for years, and the current supply situation remains difficult.

Whether you need Cefepime for a serious infection, febrile neutropenia during cancer treatment, or another condition, not being able to get your medication is stressful. This article explains why Cefepime is so hard to find and what steps you can take.

What Is Cefepime?

Cefepime (brand name Maxipime) is a fourth-generation cephalosporin antibiotic. It's one of the most important antibiotics used in hospitals across the United States. Doctors prescribe it for serious bacterial infections including:

• Pneumonia — including hospital-acquired pneumonia
• Urinary tract infections — especially complicated or severe cases
• Skin and soft tissue infections
• Febrile neutropenia — a dangerous condition in cancer patients with weakened immune systems
• Intra-abdominal infections — when combined with other antibiotics

Cefepime is administered by IV (intravenous) infusion or intramuscular injection. It is not available as a pill or oral medication, which means patients typically receive it in a hospital, infusion center, or through home infusion therapy. For a detailed overview, read our guide on what Cefepime is and how it's used.

Why Is Cefepime So Hard to Find?

There are several reasons why Cefepime has become difficult to find in 2026. The shortage is not caused by a single issue — it's a combination of manufacturing, supply chain, and market factors.

1. Manufacturing Delays and Quality Issues

Injectable antibiotics like Cefepime require specialized sterile manufacturing facilities. These facilities must meet strict FDA quality standards. When a manufacturer runs into equipment problems, contamination concerns, or needs to upgrade facilities, production can slow down or stop entirely.

B. Braun, one of the major manufacturers of Cefepime, has reported shortages due to ongoing manufacturing delays. When one manufacturer falls behind, it puts pressure on the entire supply chain because there are only a handful of companies making this drug.

2. Limited Number of Manufacturers

Unlike common oral medications that may have dozens of generic manufacturers, sterile injectable drugs like Cefepime are made by only a few companies. In the U.S., the main manufacturers include B. Braun, Apotex, Baxter, and Hospira (Pfizer). When even one of these companies has a supply disruption, it can cause a nationwide shortage.

3. Increased Demand

Demand for Cefepime has grown as antibiotic resistance patterns have changed. More bacteria are now resistant to older, narrower-spectrum antibiotics, which means doctors increasingly turn to broad-spectrum options like Cefepime. Hospitals treating cancer patients, ICU patients, and transplant recipients all rely heavily on this drug.

4. Supply Chain Vulnerabilities

The raw materials and components needed to manufacture Cefepime — including the active pharmaceutical ingredient (API) and sterile packaging — often come from a limited number of global suppliers. Disruptions anywhere in this chain can delay production for months.

What You Can Do If You Can't Find Cefepime

If Cefepime has been prescribed for you or a loved one and it's unavailable, here are practical steps to take:

Use Medfinder to Check Availability

Visit Medfinder to check which pharmacies and facilities near you have Cefepime in stock. Medfinder tracks real-time availability so you don't have to call dozens of places. For more tips, see our guide on how to find Cefepime in stock near you.

Talk to Your Doctor About Alternatives

If Cefepime is truly unavailable, your doctor may be able to prescribe an alternative antibiotic that works for your specific infection. Common alternatives include:

• Ceftazidime (Fortaz) — a third-generation cephalosporin with similar Pseudomonas coverage
• Piperacillin-Tazobactam (Zosyn) — a broad-spectrum option often used in hospitals
• Meropenem (Merrem) — a carbapenem reserved for more resistant infections

Learn more about these options in our article on alternatives to Cefepime.

Ask About Home Infusion Services

If your hospital is out of Cefepime but home infusion pharmacies have supply, ask your care team about completing your antibiotic course at home through IV therapy. Home infusion pharmacies sometimes source medications differently than hospital pharmacies.

Contact Your Hospital's Pharmacy Department

Hospital pharmacists often have the most up-to-date information about when a drug will be back in stock. They may also be able to source Cefepime from alternative distributors or recommend a suitable substitute.

Final Thoughts

The Cefepime shortage is a real and ongoing challenge in 2026. It's caused by a combination of manufacturing problems, limited producers, rising demand, and fragile supply chains. While the situation can feel overwhelming, there are steps you can take to find the medication you need.

Start by checking Medfinder for real-time availability. Talk to your healthcare provider about your options. And remember — you're not alone in this. Thousands of patients and providers are navigating the same challenge, and resources exist to help.

For the latest on the Cefepime shortage, read our 2026 shortage update for patients.